P2U purinoceptors: cDNA cloning, signal transduction mechanisms and structure-function analysis

CIBA Foundation Symposia

Volumn , Issue 198, 1996, Pages 193-207

  Lustig, Kevin D ^a   Weisman, Gary A ^b   Turner, John T ^b   Garrad, Richard ^b   Shiau, Andrew K ^c   Erb, Laurie ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PURINE P2 RECEPTOR; PURINE P2Y2 RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; HUMAN; MOLECULAR CLONING; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, PURINERGIC P2; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030345186     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barnard EA, Burnstock G, Webb TE 1994 G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol Sci 15:67-70
2. 2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol Sci 16:133-139
3. Boeynaems JM, Pearson JD 1990 P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms. Trends Pharmacol Sci 11:34-37
4. Brown HA, Lazarowski ER, Boucher RC, Harden TK 1991 Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5′-nucleotide receptor in human airway epithelial cells. Mol Pharmacol 40:648-655
5. Burnstock G 1972 Purinergic nerves. Pharmacol Rev 24:509-581
6. Burnstock G 1978 A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L (eds) Cell membrane receptors for drugs and hormones: a multidisciplinary approach. Raven, New York, p 107-118
7. Dalziel HH, Westfall DP 1994 Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev 46:449-166
8. 2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265:577C-606C
9. 2U purinergic receptor. Proc Natl Acad Sci USA 90:10449-10453
10. Erb L, Garrad R, Wang Y, Quinn T, Turner JT, Weisman GA 1995 Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J Biol Chem 270:4185-4188
11. Fredholm BB, Abbracchio MB, Burnstock G et al 1994 Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156
12. Gordon JL 1986 Extracellular ATP: effects, sources and fate. Biochem J 233:309-319
13. Knowles MR, Clarke LL, Boucher RC 1991 Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 325:533-538
14. LeGrice SFJ, Gruninger-Leitch F 1990 Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur J Biochem 187:307-314
15. 2U purinoceptor in neuroblastoma X glioma (NG108-15) cells. J Neurochem 60:1115-1125
16. Ljungquist C, Breitholtz A, Brink-Nilsson H, Moks T, Uhlen M, Nilsson B 1989 Immobilization and affinity purification of recombinant proteins using histidine peptide fusions. Eur J Biochem 186:563-569
17. Lustig KD, Shiau AK, Brake AJ, Julius D 1993 Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci USA 90:5113-5117
18. Mason SJ, Paradiso AM, Boucher RC 1991 Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br J Pharmacol 103:1649-1656
19. Masu Y, Nakayama K, Tamaki H, Harada Y, Kuno M, Nakanishi S 1987 cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature 329:836-838
20. O'Connor SE, Dainty IA, Leff P 1991 Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci 12:137-141
21. 2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 91:3275-3279
22. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC 1992 Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 11:1-20
23. Schambye HT, Hjorth SA, Weinstock J, Schwartz TW 1995 Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI-16) of the angiotensin type I receptor. Mol Pharmacol 47:425-431
24. Simon MI, Strathmann MP, Gautam N 1991 Diversity of G proteins in signal transduction. Science 252:802-808
25. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RAF 1994 Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132
26. Underwood DJ, Strader CD, Rivero R, Patchett AA, Greenlee W, Prendergast K 1994 Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor. Chemistry & Biology 1:211-221
27. Webb TE, Simon J, Krishek BJ et al 1993 Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324:219-225